Tisch Multiple Sclerosis Research Center of New York is pleased to share Dr. Saud A. Sadiq's slides presented at the American Academy of Neurology's (AAN) 68TH Annual Meeting in Vancouver, Canada. Neurologists from all over the world gathered to hear the exciting data presented on the Center's FDA- approved stem cell clinical trial for MS. Blitz Presentation.pdf
Tisch MS News
For Immediate Release: MS Patients Take Steps without Cane as Damage is Repaired
See the full interview at NY1 here: http://bit.ly/1RoY0x1.
Director and Chief Research Scientist of the Tisch MS Research Center of New York, Dr. Saud A. Sadiq, talks with Joan Hamburg about MS and our Phase II stem cell trial. Listen to the full interview here: http://bit.ly/1QGIeMa.
We are proud to announce Tisch Multiple Sclerosis Research Center of New York is teaming up with the Judith Jaffe Multiple Sclerosis Center at Weill Cornell Medical College for our Phase II stem cell trial for MS.
Dr. Violaine Harris- Senior Research Scientist at Tisch Multiple Sclerosis Research Center of New York talks to Brett Drummond from MStranslate about the Phase 1 & 2 stem cell trial: http://bit.ly/1TAkgFI.
New York, NY - January 13, 2016 - Tisch MS Research Center of New York (Tisch MSRCNY) announced today that it will pursue Phase II of its clinical trial, the first stem cell treatment for MS in the United States ever to move to this stage. Following the establishment of safety and tolerability in Phase I with no adverse effects, the Food and Drug Administration (FDA) advised Tisch MSRCNY to continue with its research.
On Friday, November 20th, at the International Conference on Cell-Based Therapies for Multiple Sclerosis in Lisbon, Portugal, Dr. Sadiq presented the most recent data about our FDA-approved Phase I stem cell trial. Peers from around the world came together to discuss the latest innovations in cell-based therapies for MS. Dr. Sadiq's encouraging data was well-received as it now provides some measureable results in the attempt to use stem cells to repair the damage caused by MS.
Published on Oct 15, 2015 A Manhattan clinic is dramatically changing the lives of people who battle multiple sclerosis. The treatment involves patients who use their own stem cells to fight the disease. One young mother told Fox 5 that she is already seeing results.
Here's a link to the news story and article featured this past weekend on Fox5's Best of "The Big Idea!"